Yttrium (90Y) tacatuzumab tetraxetan: Difference between revisions
Appearance
Content deleted Content added
m Bot: Migrating 1 interwiki links, now provided by Wikidata on d:q3980015 |
m Identifier not assigned: use =none (CAS RN, ChemSpider, ATC) (via AWB script) |
||
Line 5: | Line 5: | ||
| image = Y-90 tacatuzumab tetraxetan structure.svg |
| image = Y-90 tacatuzumab tetraxetan structure.svg |
||
| drug_name = Yttrium (<sup>90</sup>Y) tacatuzumab tetraxetan |
| drug_name = Yttrium (<sup>90</sup>Y) tacatuzumab tetraxetan |
||
⚫ | |||
⚫ | |||
| type = mab |
| type = mab |
||
| mab_type = mab |
| mab_type = mab |
||
| source = zu/o |
| source = zu/o |
||
| target = [[α-fetoprotein]] |
| target = [[α-fetoprotein]] |
||
⚫ | |||
⚫ | |||
| tradename = |
| tradename = |
||
| pregnancy_AU = |
| pregnancy_AU = |
||
Line 23: | Line 21: | ||
| legal_status = |
| legal_status = |
||
| routes_of_administration = |
| routes_of_administration = |
||
⚫ | |||
⚫ | |||
| bioavailability = |
| bioavailability = |
||
| protein_bound = |
| protein_bound = |
||
Line 30: | Line 27: | ||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
⚫ | |||
⚫ | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
| ChemSpiderID = |
| ChemSpiderID = none |
||
| CAS_number_Ref = {{cascite|changed|??}} |
| CAS_number_Ref = {{cascite|changed|??}} |
||
| CAS_number = 476413-07-7 |
| CAS_number = 476413-07-7 |
||
Line 41: | Line 37: | ||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
||
| DrugBank = |
| DrugBank = |
||
⚫ | |||
⚫ | |||
| chemical_formula = C<sub>6470</sub>H<sub>9971</sub>N<sub>1712</sub>O<sub>2007</sub>S<sub>42</sub><sup>90</sup>Y |
| chemical_formula = C<sub>6470</sub>H<sub>9971</sub>N<sub>1712</sub>O<sub>2007</sub>S<sub>42</sub><sup>90</sup>Y |
||
| molecular_weight = 145 [[kDa]] |
| molecular_weight = 145 [[kDa]] |
Revision as of 10:00, 20 November 2015
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Humanized (from mouse) |
Target | α-fetoprotein |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
Chemical and physical data | |
Formula | C6470H9971N1712O2007S4290Y |
Molar mass | 145 kDa |
(what is this?) (verify) |
Yttrium (90Y) tacatuzumab tetraxetan (trade name AFP-Cide) is a humanized monoclonal antibody intended for the treatment of cancer.[1] The antibody itself, tacatuzumab, is conjugated with tetraxetan, a chelator for yttrium-90,[2] a radioisotope which destroys the tumour cells.
References